Abbott India Board of Directors

Get the latest insights into the leadership at Abbott India. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Munir Shaikh Chairman
Mr. Kartik Rajendran Managing Director
Mr. Kaiyomarz Marfatia Non Executive Director
Mr. Ambati Venu Non Executive Director
Ms. Alison Davies Non Executive Director
Ms. Anisha Motwani Independent Director
Ms. Shalini Kamath Independent Director
Mr. Sudarshan Jain Independent Director

Abbott India Share price

ABBOTINDIA

32000

575.00 (-1.77%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

32755.00

Today's Low

32000.00

52 Week Low

25325.00

52 Week High

37000.00

The current prices are delayed, login to your account for live prices

Abbott India FAQs

The board at Abbott India consists of experienced professionals, including Mr. Munir Shaikh , Mr. Kartik Rajendran , and others, overseeing the company’s strategic and corporate governance.

Directors at Abbott India are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Munir Shaikh is the current chairman at Abbott India.

Executive directors at Abbott India are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Abbott India adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Abbott India, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.